MS is a neurological disease that predominantly affects young adults. Pain can be a significant problem for a substantial proportion of people with MS. It can have a severe impact on activities of daily living and can be difficult to manage with medications.
The aim of this study is to assess the long-lasting effect of a non-invasive brain stimulation technique on pain reduction and improving the quality of life in people with MS. This treatment will be delivered with a battery-operated device which is very safe with very little side effects (e.g. mild itching sensation under one of the electrodes). If this stimulation technique is effective in reducing pain for several weeks, it may provide a new option for pain relief and pain management in people with MS who experience pain.
Dr Maryam and her team have successfully completed all administrative tasks required to obtain ethics approval and are now ready to recruit participants for the study. They have also collaborated effectively with specialists in the field to ensure the success of the project.
Through their experience, Dr Zoghi and her team have gained valuable insights into the importance of flexibility and adaptability in conducting clinical trials, particularly in light of unforeseen events such as participant illness or other personal emergencies that can impact trial participation. They also recognise the significance of virtual communication and remote monitoring.
These experiences and lessons learned will undoubtedly prove invaluable in their future research endeavours.
Updated: 31 March 2023
Updated: 16 November, 2021
Laboratory research that investigates scientific theories behind the possible causes, disease progression, ways to diagnose and better treat MS.
Research that builds on fundamental scientific research to develop new therapies, medical procedures or diagnostics and advances it closer to the clinic.
Clinical research is the culmination of fundamental and translational research turning those research discoveries into treatments and interventions for people with MS.